Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy

NACompletedINTERVENTIONAL
Enrollment

382

Participants

Timeline

Start Date

June 21, 2019

Primary Completion Date

October 31, 2020

Study Completion Date

October 31, 2020

Conditions
Obesity
Interventions
DIAGNOSTIC_TEST

NASHMIR

An additional blood sample will be taken upstream of the surgical procedure and a liver biopsy will be performed in all included patients. The two results obtained by the spectroscopic test and by means of the biopsy will then be compared to determine the diagnostic performance of the developped test (NASHMIR test).

Trial Locations (1)

4000

CHU de Liège, Liège

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Clinact

OTHER

lead

Diafir

INDUSTRY

NCT03978247 - Signature Diagnostic of Non-alcoholic Steatohepatitis (NASH) by Infrared Light Spectroscopy | Biotech Hunter | Biotech Hunter